WaveMan
WaveMan · Company
CJMB · Callan Jmb Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

CJMB Callan JMB (CJMB) Insider Trading, Ownership & Congress Trades

Services · Services-business services, nec · CIK 0002032545
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
7
13F, latest reported quarter

Callan JMB insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for CALLAN JMB INC. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Croyle David J
Chief Medical Officer
BUY
2026-03-26 SECtraded 2026-03-20
10,195
$17.8K
-61.7%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 6, 2026.
  • +14.7% median (-6.4% mean) 90-day return after 3 previous buys.
  • The trade is 1.3% of the 800,000 shares held after it.
  • No other insider bought within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Medical Officer Croyle David J bought about $17.8K of CJMB on Mar 20, 2026; 7 funds added in the latest 13F quarter.
Croyle David J
Chief Medical Officer
BUY
2026-03-10 SECtraded 2026-03-06
14,805
$26.1K
-73.5%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Mar 27, 2025.
  • +17.3% median (+17.3% mean) 90-day return after 2 previous buys.
  • The trade is 1.9% of the 789,805 shares held after it.
  • No other insider bought within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Medical Officer Croyle David J bought about $26.1K of CJMB on Mar 6, 2026; 7 funds added in the latest 13F quarter.
Dial Gerald
Director
BUY
2026-01-06 SECtraded 2025-12-30
1,539
$1.8K
-58.1%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 77.0% of the 2,000 shares held after it.
  • 2 other insiders bought within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Dial Gerald bought about $1.8K of CJMB on Dec 30, 2025; 2 other insiders bought within 30 days and 7 funds added in the latest 13F quarter.
Dial Gerald
Director
BUY
2026-01-06 SECtraded 2025-12-30
461
$562
-58.1%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 461 shares held after it.
  • 2 other insiders bought within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Dial Gerald bought about $562 of CJMB on Dec 30, 2025; 2 other insiders bought within 30 days and 7 funds added in the latest 13F quarter.
Dial Gerald
Director
BUY
2026-06-01 SECtraded 2025-12-30
10,000
$7.6K
-36.3%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 83.3% of the 12,000 shares held after it.
  • 2 other insiders bought within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Dial Gerald bought about $7.6K of CJMB on Dec 30, 2025; 2 other insiders bought within 30 days and 7 funds added in the latest 13F quarter.
18 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 13 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
7 funds bought in last quarter
below 83% of Services
Revenue
-12.8% year over year
below 84% of Services
Margin
-139.2% net margin
below 93% of Services
Buybacks
no share repurchases reported
Short interest
5.7% of the float short (float per yahoo 2026-10-26) · 1.5 days to cover · settled 2026-09-30
below 51% of Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch CJMB

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-88.3%12M
-88%-59%-29%+0%2025-102025-122026-022026-042026-062026-082026-10 2025-12-11 · Williams Wayne D bought $50.9K2026-03-06 · Croyle David J bought $26.1K2025-12-10 · Williams Wayne D bought $22.6K2025-12-15 · Williams Wayne D bought $18.4K2026-03-20 · Croyle David J bought $17.8K2025-12-16 · Williams Wayne D bought $8.7K2025-12-12 · Williams Wayne D bought $8.6K2025-12-30 · Dial Gerald bought $7.6K2025-12-30 · Dial Gerald bought $1.8K2025-12-08 · Duke Liberty Smith bought $1.4K2025-12-09 · Duke Liberty Smith bought $9302025-12-30 · Dial Gerald bought $5622025-12-11 · Williams Wayne D bought $111
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns CJMB: institutional holders (13F)

13F holdings, latest reported quarter
Qsemble Capital Management, LP
1,561 sh
$377.7K
Creative Planning
255,693 sh
$205.6K
BARD ASSOCIATES INC
229,250 sh
$184.3K
CITADEL ADVISORS LLC
32,086 sh
$25.8K
AXXCESS WEALTH MANAGEMENT, LLC
25,000 sh
$20.1K

Congress trades in CJMB

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

CJMB planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

CJMB mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Extended Market Index Fund
$13.3K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$5.4K position · as of 2026-06-30
0.0%
Fidelity Series Total Market Index Fund
$1.5K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 7 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
DASHABNBSEETSYFICOXMTRACNZGFLYWMAMAXPHR

CJMB financials

Revenue growth
-12.8%
XBRL, annual
Net margin
-139.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.1M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-192.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$4.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.00x
current debt only, 2024-12-31 (18 months older than the period end); equity 2026-06-30
Cash flow to debt
n/a
no debt to cover
Return on equity
-300.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-145.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-138.8%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$2.0M
market value at close 2026-10-26 on 2026-08-12 shares, plus current debt only, 2024-12-31 (18 months older than the period end), minus cash 2026-06-30
FCF yield
-168.0%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-12
Revenue$5.7M$6.6M$13.2M
Gross profit$2.1M$2.6M$5.6M
Operating income-$7.0M-$2.3M$2.2M
Net income-$8.0M-$2.3M$2.2M
EPS (diluted)-1.82-0.87n/a
Operating cash flow-$4.5M$540.4K$7.0M
Cash$2.1M$2.1M$5.2M
Dividends paidn/a$3.3M$7.4M
SEC XBRL, fiscal years, as known on 2026-10-28

CJMB Stock Sonar score 5/7 axes

Find similar shapesCompare

CJMB ranks highest on financial health (99th percentile) and risk and compliance (46th), and lowest on profitability (6th), among Services peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
6
Inputs
  • Return on equity-300.3% · 4 pct, sector of 207
  • Return on assets-145.7% · 12 pct, sector of 269
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-138.8% · 3 pct, sector of 203
Financial health
100
Inputs
  • Debt to equity0.00x · 100 pct, sector of 228
  • Cash flow to debtno debt to cover
Growth
16
Inputs
  • Revenue growth, YoY-12.8% · 16 pct, sector of 341
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
17
Inputs
  • Funds adding, latest quarter7 · 17 pct, sector of 243
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
46
Inputs
  • Short interest, % of float+5.7% · 33 pct, sector of 383
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+9.3% · 59 pct, sector of 227
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies